Get the Stockscreener App
39.00
0.31%
0.1204
Tema Oncology Etf stock is traded at $39.00, with a volume of 20,591.
It is up +0.31% in the last 24 hours and up +8.39% over the past month.
See More
Previous Close:
$38.88
Open:
$39
24h Volume:
20,591
Relative Volume:
0.67
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.21%
1M Performance:
+8.39%
6M Performance:
+29.17%
1Y Performance:
+69.98%
1-Day Range:
$38.39
$39.16
1-Week Range:
$37.14
$39.16
52-Week Range:
$22.48
$39.16
Tema Oncology Etf Stock (CANC) Company Profile
Name
Tema Oncology Etf
Sector
Industry
Phone
-
Address
-
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
39.00 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
345.24 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
699.94 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
703.19 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
278.28 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
637.40 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Stock (CANC) Latest News
Discipline and Rules-Based Execution in CANC Response - Stock Traders Daily
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks - Seeking Alpha
CANC Stock Price, Quote & Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
CANC: First Look At This Addressing Cancer ETF Results In A Hold Rating (Retired Investor) (NASDAQ:CANC) - Seeking Alpha
Behavioral Patterns of CANC and Institutional Flows - Stock Traders Daily
(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Biotech stocks and longevity investing: Trends to track - North Scott Press
CANC Stock Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
Why Is Cogent Biosciences Stock Surging Monday?Cogent Biosciences (NASDAQ:COGT) - Benzinga
Land and Houses Asset Management launches LHLONGEVITY, investing in innovative cancer treatment stocks. - moneyandbanking.co.th
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application - sahmcapital.com
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share - AOL.com
ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView
How (CANC) Movements Inform Risk Allocation Models - Stock Traders Daily
2 Under-the-Radar Stocks to Buy and Hold - AOL.com
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - MSN
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
F/m High Yield 100 ETF (NASDAQ:ZTOP) Shares Down 0.2% – Time to Sell? - Defense World
Trading Systems Reacting to (CANC) Volatility - Stock Traders Daily
11 Best Cancer Stocks to Invest In Now - Insider Monkey
How Tema Oncology Etf (CANC) Affects Rotational Strategy Timing - Stock Traders Daily
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC - Defense World
(CANC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
2 Stocks That Could Soar This Year - AOL.com
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - AOL.com
Responsive Playbooks and the CANC Inflection - Stock Traders Daily
Understanding the Setup: (CANC) and Scalable Risk - Stock Traders Daily
Tema Oncology ETF (NQ: CANC - FinancialContent
Here's Why Biotech ETFs Are Rallying Hard - Zacks Investment Research
Los Angeles Daily NewsTema Oncology ETF (Nasdaq:CANC) Stock Quote - FinancialContent
The Technical Signals Behind (CANC) That Institutions Follow - Stock Traders Daily
Biotech Market Forecast: Top Trends for Biotech in 2026 - Investing News Network
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView — Track All Markets
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Be Thankful to These ETFs This Year - sharewise.com
Inside the Recent Strength in Biotech ETFs - TradingView
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Nasdaq
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
Tema Launches Alternative Asset Managers ETF (AAUM) - Business Wire
Tema Launches First International Defense Innovation ETF (GDFN) - Business Wire
2 Growth Stocks to Buy and Hold Forever - AOL.com
Tema Launches International Durable Quality ETF (ITOL) - Business Wire
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Tema Announces Liquidation of Two ETFs - Business Wire
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
Tema Oncology Etf Stock (CANC) Financials Data
There is no financial data for Tema Oncology Etf (CANC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):